Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics

NCT01001962 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1054

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Type II Diabetes

Interventions

DRUG: empagliflozin
DRUG: Metformin

Sponsor

Aristotle University Of Thessaloniki